Modular Facility Proof-of-Concept for Multi-Modal Bioprocessing: an innovative solution

by Thomas Hauser and Jérome Dalin | November 29, 2022

Vaccines Webinar 1st December 2022

This webinar describes the collaboration of

Merck KGaA, Darmstadt, Germany
MilliporeSigma
, and G-CON to develop a proof-of-concept facility design that enables multi-modal bioprocessing with greater flexibility and agility which facilitates tech transfer and future expansion. Details about the design, timelines, and cost repartition will be included.

In this presentation you will explore:

• How to develop a proof-of-concept facility design that supports multi-modal bioprocessing
• Details about the specific design, timelines, and costs
• How this modular facility approach can be leveraged for your specific requirements

Register here

Related Posts

Starting your journey into manufacturing – choosing a cell line development provider

One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …

Covid-19 Impact on Bioprocessing: PART 1 Accelerating Trends

The views and opinions expressed in this blog / article are those of the authors and do not…

Covid-19 Impact on Bioprocessing: PART 2 Fears to Be Addressed due to Covid-19

The views and opinions expressed in this blog / article are those of the authors and do not…

Covid-19 Impact on Bioprocessing: PART 3 Long-term Changes Resulting from the Pandemic

The views and opinions expressed in this blog / article are those of the authors and do not…

Scroll to Top